|
|
| | Aclacinomycin B Basic information |
| Product Name: | Aclacinomycin B | | Synonyms: | Aclacinomycin B;1-Naphthacenecarboxylic acid, 4-[[[2''',3''-anhydro]-O-3,6-dideoxy-α-L-erythro-hexopyranos-4-ulos-1-yl-(1→4)-O-2,6-dideoxy-α-L-lyxo-hexopyranosyl-(1→4)-2,3,6-trideoxy-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-, methyl ester, (1R,2R,4S)- | | CAS: | 57596-79-9 | | MF: | C42H51NO15 | | MW: | 809.86 | | EINECS: | | | Product Categories: | | | Mol File: | 57596-79-9.mol |  |
| | Aclacinomycin B Chemical Properties |
| Melting point | 163-167° (dec) | | alpha | D24 +3° (c = 1 in methylene chloride) | | Boiling point | 873.0±65.0 °C(Predicted) | | density | 1.44±0.1 g/cm3(Predicted) | | pka | 6.41±0.70(Predicted) |
| Toxicity | LD50 in mice (mg/kg): 13.7 i.p., 16.4 i.v. (Oki) |
| | Aclacinomycin B Usage And Synthesis |
| | Aclacinomycin B Preparation Products And Raw materials |
|